According to FutureWise analysis, the market for Migraine Treatment in 2023 was US$ 2.83 billion and is expected to reach US$ 5.64 billion by 2031 at a CAGR of 9.02%. Migraine is a debilitating neurological disorder characterized by recurrent episodes of intense throbbing head pain that can persist for up to three days. These headaches are often unilateral, meaning they typically affect one...